18165852|t|Early prevention at public health issue.
18165852|a|Alzheimer's Disease and related disorders have recently become a priority in France and two consecutive governmental plans have been undertaken in 2001-2004 and 2004-2007. The number of prevalent cases was estimated to be 850,000 in France with an incidence of 220,000 cases. Only 50% of these cases were actually diagnosed and about 32% were treated by antidementia drugs. If the incidence and the duration of the disease do not change, the number of cases will increase to 1,200,000 in 2020 and 2,100,000 cases in 2040. In absence of curative treatment, the prevention way is necessary if one wishes to control this phenomena. The development of Memory Clinics and "Centres de Memoires de Ressources et de Recherche" in all regions in France is one of the important measures to develop primary and secondary prevention in subjects with cognitive complaints or MCI. Several factors could be the basis of this prevention 1) Vascular risk factors (High Blood Pressure, Diabetes, Obesity, Hypercholesterolemiae, Tobacco consumption) ; 2) physical exercise ; 3) Stimulating cognitive activities ; 4) Nutrition ; 5) depressive disorders and loneliness.
18165852	41	60	Alzheimer's Disease	Disease	MESH:D000544
18165852	879	899	cognitive complaints	Disease	MESH:D003072
18165852	903	906	MCI	Disease	
18165852	1009	1017	Diabetes	Disease	MESH:D003920
18165852	1019	1026	Obesity	Disease	MESH:D009765
18165852	1028	1049	Hypercholesterolemiae	Disease	MESH:D006937
18165852	1153	1173	depressive disorders	Disease	MESH:D003866
18165852	1178	1188	loneliness	Disease	

